Diploma (LON:DPLM) Sets New 1-Year High – Should You Buy?

Diploma PLC (LON:DPLM)’s stock price hit a new 52-week high during trading on Friday . The stock traded as high as GBX 5,640 ($75.18) and last traded at GBX 5,625 ($74.98), with a volume of 658438 shares. The stock had previously closed at GBX 5,555 ($74.05).

Wall Street Analyst Weigh In

Several analysts recently issued reports on the company. Royal Bank Of Canada upgraded Diploma to an “outperform” rating and upped their target price for the stock from GBX 4,500 to GBX 6,000 in a report on Friday, October 3rd. Jefferies Financial Group upped their target price on Diploma from GBX 4,500 to GBX 5,200 and gave the stock a “hold” rating in a report on Thursday, September 11th. Berenberg Bank upped their target price on Diploma from GBX 5,750 to GBX 6,350 and gave the stock a “buy” rating in a report on Wednesday, September 10th. JPMorgan Chase & Co. restated a “neutral” rating and set a GBX 4,440 price objective on shares of Diploma in a research note on Wednesday, August 6th. Finally, Shore Capital reiterated a “hold” rating and issued a GBX 5,100 price target on shares of Diploma in a research note on Thursday, July 17th. Three equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of GBX 5,365.

Diploma Stock Performance

The stock’s 50-day simple moving average is GBX 5,388.85 and its 200-day simple moving average is GBX 4,883.86. The stock has a market cap of £7.54 billion, a price-to-earnings ratio of 45.23, a price-to-earnings-growth ratio of 2.82 and a beta of 0.75. The company has a current ratio of 2.17, a quick ratio of 0.80 and a debt-to-equity ratio of 62.17.

About Diploma

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.